Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 19, 2018 - Issue 2
Submit an article Journal homepage
3,568
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Safety and efficacy of long-term treatment with teneligliptin: Interim analysis of a post-marketing surveillance of more than 10,000 Japanese patients with type 2 diabetes mellitus

Takashi KadowakiDepartment of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, JapanView further author information
,
Masakazu HanedaDepartment of Medicine, Asahikawa Medical University, Hokkaido, Japan;Medical Corporation Kyousoukai, Osaka, JapanView further author information
,
Hiroshi ItoDepartment of Cardiovascular Medicine, Okayama University, Okayama, JapanView further author information
,
Makoto UenoIkuyaku. Integrated Value Development Division, Mitsubishi Tanabe Pharma Corporation, Osaka, JapanView further author information
,
Miyuki MatsukawaIkuyaku. Integrated Value Development Division, Mitsubishi Tanabe Pharma Corporation, Osaka, JapanView further author information
,
Tomoko YamakuraIkuyaku. Integrated Value Development Division, Mitsubishi Tanabe Pharma Corporation, Osaka, JapanView further author information
,
Kazuyo SasakiIkuyaku. Integrated Value Development Division, Mitsubishi Tanabe Pharma Corporation, Osaka, JapanView further author information
,
Mayumi KimuraIkuyaku. Integrated Value Development Division, Mitsubishi Tanabe Pharma Corporation, Osaka, JapanView further author information
&
Hiroaki IijimaIkuyaku. Integrated Value Development Division, Mitsubishi Tanabe Pharma Corporation, Tokyo, JapanCorrespondence[email protected]
View further author information
 show all
Pages 83-91 | Received 01 Nov 2017, Accepted 19 Dec 2017, Published online: 19 Jan 2018

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.